LifeNet Health’s 3D HuBiogel™ supports the only fully-human, tissue-like bioassay system for accelerating preclinical research and drug development. Our proprietary cell culture technology replicates the biology and microenvironment of normal and diseased tissues ex vivo, and a series of high-throughput microtumor culture/assay systems offer rapid yet accurate efficacy evaluation of preclinical drug candidates and prediction of their potential toxicity.

The LifeSciences Division offers a range of services including: 

Optimized use of primary human cells enables more reliable study of the functionality and interaction of organ systems, tissues, and cells. Timely access to the highest quality tissues allows for rapid isolation of primary cells for research. LifeNet Health is able to create new cell products according to customer requests and specifications.

LifeNet Health has access to organs and tissues from both normal and diseased donors to support research needs. There are increasing needs to meet the demand from researchers for high-quality, well-characterized tissues. This includes base materials, cells, and growth factors which can be derived from these research tissues. Our biospecimens support unmet needs at academic and research institutes, and pharmaceutical, reagent, and biotech companies.

LifeNet Health Europe GmbH
Terms & Conditions

To help spread the message of National Donate Life Month, LifeNet Health has made available a simple infographic to highlight the impact of organ, eye and tissue donation. 

Click here to register.